NCT03079661 (PolluBPCO) is a clinical trial in Acute Exacerbation Copd, sponsored by Centre Hospitalier Universitaire, Amiens.

Who is sponsoring NCT03079661?

NCT03079661 is sponsored by Centre Hospitalier Universitaire, Amiens.

What condition does NCT03079661 study?

NCT03079661 studies Acute Exacerbation Copd.

Is NCT03079661 still recruiting?

NCT03079661 is currently terminated. Last updated 15 July 2020.

Last reviewed 2020-07-15 · How we verify

NCT03079661: PolluBPCO

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of Air Quality on Exacerbations of COPD in the Somme

Terminated Last updated 15 July 2020

What this trial tests

trial in Acute Exacerbation Copd in 179 participants. Terminated before completion.

Timeline

1 January 2017

Primary endpoint
14 January 2019

14 January 2019

Quick facts

Lead sponsor	Centre Hospitalier Universitaire, Amiens
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	179
Start date	1 January 2017
Primary completion	14 January 2019
Estimated completion	14 January 2019
Sites	1 location across France

Conditions studied

Acute Exacerbation Copd — all drugs for Acute Exacerbation Copd →

Sponsor

Centre Hospitalier Universitaire, Amiens

Who can join

Eligibility, any sex, with Acute Exacerbation Copd. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

All COPD patients with a diagnosis of acute exacerbation in emergency room in University Hospital of Amiens-Picardie between 01/01/2017 and 31/12/2017. The investigator will collect for each patient the home address and the work address. The duration of 1 year was chosen to take into account seasonal variations. In parallel, a daily report of the rate of ozone, particles (PM2.5 and PM10), dioxide nitrogen but also odours and pollens will be done by ATMO Picardie.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Association between acute exacerbation of chronic obstructive pulmonary disease and short-term exposure to ambient air pollutants in France.
Basille D, Soriot L, Weppe F, Desmettres P, et al · · 2024 · cited 2× · PMID 39614356 · DOI 10.1186/s12940-024-01146-3

Verify or expand the search:

Other Centre Hospitalier Universitaire, Amiens trials

Trials by the same sponsor.

NCT07354568 — Prognosis of Patients With Mixed Cardiogenic-Vasoplegic Shock · recruiting
NCT07071662 — Induction of Labor in Breech Presentation · completed
NCT06909487 — Clinical Characterization of Very and Extremely Preterm Infants Who Received Excess Erythrocyte Transfusions With Respec · completed
NCT07037719 — Automatic Detection of Eligible Patients to RAUC Protocol (RAUCISABLE) · recruiting
NCT06996145 — Study of the Isometry of the Anterior Cruciate Ligament From the Center of the Native MRI Insertion Reported on Dynamic · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03079661 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire, Amiens
Last refreshed: 15 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03079661.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing